 pharmacodynam cancer therapi understand anticanc pharmacodynam relationship pharmacolog measur clinic effect recent year due advanc analyt comput technolog methotrex plasma level leucovorin high-dos methotrex therapi standard use therapeut drug monitor oncolog investig dose antineoplast agent model real-tim analysi plasma drug tissu concentr studi progress hexamethylen bisacetamid fluorouracil fura cytarabin ara-c futur studi optim sampl strategi analysi intermedi biochem end point combin chemotherapi modul colony-stimul factor sophist pharmacodynam model